<DOC>
	<DOCNO>NCT00729768</DOCNO>
	<brief_summary>This Phase II/III , randomize , open-label , active-controlled , multicenter trial evaluate safety efficacy efalizumab compare cyclosporine ( CsA ) , give combination Mycophenolate Mofetil ( MMF ) corticosteroids induction therapy basiliximab , immunosuppressant regimen de novo renal transplantation . A total 200 subject undergo either live cadaveric renal transplantation randomly assign 1:1 receive either efalizumab + MMF + corticosteroid CsA + MMF + corticosteroid .</brief_summary>
	<brief_title>A Study Evaluate Efalizumab Compared With Cyclosporine As Immunosuppressant Regimen De Novo Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Key Have sign inform consent form HIPAA patient information form ( United States ) Are â‰¥ 18 year age Are transplant recipient least one HLAmismatch kidney For subject reproductive potential ( men woman ) , willing use effective contraception , unless abstinence choose method Key Have history previous renal transplant Have PRA &gt; 25 % time Have history evidence cancer except basal cell carcinoma excise cervical carcinoma situ Have positive Tcell lymphocytotoxic crossmatch use donor lymphocytes recipient serum Have previous treatment efalizumab Have use investigational drug within 28 day 5 halflives screen , whichever longer Have know contraindication efalizumab Have history severe allergic anaphylactic reaction monoclonal antibody Have know allergic reaction intolerance follow medication : CsA ; MMF ; Corticosteroids ; Basiliximab Are allergic iodinate contrast medium would preclude GFR measurement iothalamate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Renal transplant</keyword>
	<keyword>Raptiva</keyword>
</DOC>